Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Evaluating the economic implications of cardiovascular therapeutics.
Publication
, Journal Article
Califf, RM
Published in: Am Heart J
May 1999
Duke Scholars
Published In
Am Heart J
DOI
ISSN
0002-8703
Publication Date
May 1999
Volume
137
Issue
5
Start / End Page
S35 / S37
Location
United States
Related Subject Headings
- Humans
- Economics, Pharmaceutical
- Drug Costs
- Developed Countries
- Cost-Benefit Analysis
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- Cardiovascular Agents
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
Citation
APA
Chicago
ICMJE
MLA
NLM
Califf, R. M. (1999). Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Evaluating the economic implications of cardiovascular therapeutics. Am Heart J, 137(5), S35–S37. https://doi.org/10.1016/s0002-8703(99)70425-4
Califf, R. M. “Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Evaluating the economic implications of cardiovascular therapeutics.” Am Heart J 137, no. 5 (May 1999): S35–37. https://doi.org/10.1016/s0002-8703(99)70425-4.
Califf RM. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Evaluating the economic implications of cardiovascular therapeutics. Am Heart J. 1999 May;137(5):S35–7.
Califf, R. M. “Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Evaluating the economic implications of cardiovascular therapeutics.” Am Heart J, vol. 137, no. 5, May 1999, pp. S35–37. Pubmed, doi:10.1016/s0002-8703(99)70425-4.
Califf RM. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Evaluating the economic implications of cardiovascular therapeutics. Am Heart J. 1999 May;137(5):S35–S37.
Published In
Am Heart J
DOI
ISSN
0002-8703
Publication Date
May 1999
Volume
137
Issue
5
Start / End Page
S35 / S37
Location
United States
Related Subject Headings
- Humans
- Economics, Pharmaceutical
- Drug Costs
- Developed Countries
- Cost-Benefit Analysis
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- Cardiovascular Agents
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services